Hancom Lifecare Inc. (KRX:372910)
South Korea · Delayed Price · Currency is KRW 1,983.00
+17.00 (0.86%)
At close: Jun 12, 2026
Hancom Lifecare Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 91,433 | 92,088 | 104,776 | 112,780 | 100,120 | 121,140 |
Other Revenue | - | -0 | - | - | -0 | - |
| 91,433 | 92,088 | 104,776 | 112,780 | 100,120 | 121,140 | |
Revenue Growth (YoY) | -6.49% | -12.11% | -7.10% | 12.64% | -17.35% | -20.22% |
Cost of Revenue | 71,549 | 70,916 | 75,875 | 89,332 | 80,478 | 93,418 |
Gross Profit | 19,884 | 21,173 | 28,902 | 23,448 | 19,642 | 27,722 |
Selling, General & Admin | 19,224 | 20,046 | 19,481 | 19,403 | 18,634 | 20,480 |
Research & Development | 280.82 | 267.09 | 234.02 | 440.61 | 798.4 | 530.5 |
Amortization of Goodwill & Intangibles | 433.11 | 447.56 | 437.01 | 459.96 | 561.22 | 606.56 |
Other Operating Expenses | 262.72 | 348.65 | 354.32 | 364.49 | 412.76 | 239.3 |
Operating Expenses | 26,845 | 27,750 | 21,485 | 21,616 | 21,065 | 22,942 |
Operating Income | -6,961 | -6,578 | 7,416 | 1,832 | -1,423 | 4,781 |
Interest Expense | -23.03 | -25.59 | -31.45 | -182.08 | -131.58 | -468.74 |
Interest & Investment Income | 471.85 | 533.18 | 478.1 | 650.33 | 736.56 | 104.71 |
Currency Exchange Gain (Loss) | 1,016 | 177.2 | 1,207 | 256.32 | -142.03 | 788.62 |
Other Non Operating Income (Expenses) | -2,345 | -2,719 | -70.69 | -382.05 | -914.27 | -904.66 |
EBT Excluding Unusual Items | -7,841 | -8,612 | 9,000 | 2,175 | -1,874 | 4,301 |
Gain (Loss) on Sale of Investments | 266.2 | 118.64 | 8.87 | 5.33 | 23,920 | -39.44 |
Gain (Loss) on Sale of Assets | -383.81 | -359.03 | 73.98 | 157.83 | -18.34 | 1,333 |
Asset Writedown | -521.58 | -521.58 | - | -713.2 | -8,791 | - |
Pretax Income | -8,480 | -9,374 | 9,082 | 1,625 | 13,236 | 5,594 |
Income Tax Expense | -1,397 | -1,708 | 1,747 | 753.4 | 3,966 | 759.05 |
Earnings From Continuing Operations | -7,083 | -7,666 | 7,336 | 871.12 | 9,269 | 4,835 |
Minority Interest in Earnings | -80.8 | -59.43 | 38.76 | -46.41 | -65.47 | - |
Net Income | -7,164 | -7,725 | 7,375 | 824.71 | 9,204 | 4,835 |
Net Income to Common | -7,164 | -7,725 | 7,375 | 824.71 | 9,204 | 4,835 |
Net Income Growth | - | - | 794.20% | -91.04% | 90.36% | -82.54% |
Shares Outstanding (Basic) | 28 | 28 | 28 | 28 | 28 | 25 |
Shares Outstanding (Diluted) | 28 | 28 | 28 | 28 | 28 | 25 |
Shares Change (YoY) | - | - | - | - | 12.31% | -1.17% |
EPS (Basic) | -258.86 | -279.14 | 266.48 | 29.80 | 332.58 | 196.22 |
EPS (Diluted) | -259.00 | -279.14 | 266.00 | 29.80 | 332.58 | 196.00 |
EPS Growth | - | - | 792.60% | -91.04% | 69.68% | -84.94% |
Free Cash Flow | 12,650 | 16,962 | 18,164 | -13,550 | -681.63 | 18,826 |
Free Cash Flow Per Share | 457.11 | 612.90 | 656.33 | -489.62 | -24.63 | 764.02 |
Gross Margin | 21.75% | 22.99% | 27.58% | 20.79% | 19.62% | 22.88% |
Operating Margin | -7.61% | -7.14% | 7.08% | 1.62% | -1.42% | 3.95% |
Profit Margin | -7.83% | -8.39% | 7.04% | 0.73% | 9.19% | 3.99% |
Free Cash Flow Margin | 13.84% | 18.42% | 17.34% | -12.01% | -0.68% | 15.54% |
EBITDA | -2,324 | -1,797 | 13,020 | 8,916 | 5,800 | 12,611 |
EBITDA Margin | -2.54% | -1.95% | 12.43% | 7.91% | 5.79% | 10.41% |
D&A For EBITDA | 4,637 | 4,781 | 5,604 | 7,084 | 7,223 | 7,831 |
EBIT | -6,961 | -6,578 | 7,416 | 1,832 | -1,423 | 4,781 |
EBIT Margin | -7.61% | -7.14% | 7.08% | 1.62% | -1.42% | 3.95% |
Effective Tax Rate | - | - | 19.23% | 46.38% | 29.97% | 13.57% |
Advertising Expenses | - | 511.69 | 706.96 | 764.06 | 1,094 | 865.79 |